Mole et al. reported a case of Hodgkin lymphoma in a patient with AS post-anti-tumor necrosis factor (anti-TNF) therapy, reinforcing the importance of clinical suspicion in similar scenarios [5]. This evidence concerns the gene TNF and Hodgkins lymphoma.